Literature DB >> 14742816

Myelodysplastic syndrome associated with low-dose methotrexate in rheumatoid arthritis.

Hiroshi Okamoto, Masanao Teramura, Naoyuki Kamatani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14742816     DOI： 10.1345/aph.1D117

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN： 1060-0280            Impact factor:   3.154


× No keyword cloud information.
  6 in total

1.  The age-risk relationship of hematologic malignancies in patients with rheumatoid arthritis: a nationwide retrospective cohort study.

Authors:  Yu-Chih Lin; Hui-Wen Chou; Wen-Chan Tsai; Jeng-Hsien Yen; Shun-Jen Chang; Yi-Ching Lin
Journal:  Clin Rheumatol       Date:  2015-05-20       Impact factor: 2.980

Review 2.  Acute myeloid leukemia developing in patients with autoimmune diseases.

Authors:  Safaa M Ramadan; Tamer M Fouad; Valentina Summa; Syed Kh Hasan; Francesco Lo-Coco
Journal:  Haematologica       Date:  2011-12-16       Impact factor: 9.941

3.  Co-existence of acute myeloid leukemia with multilineage dysplasia and Epstein-Barr virus-associated T-cell lymphoproliferative disorder in a patient with rheumatoid arthritis: a case report.

Authors:  Michihide Tokuhira; Kyoko Hanzawa; Reiko Watanabe; Yasunobu Sekiguchi; Tomoe Nemoto; Yasuo Toyozumi; Jun-ichi Tamaru; Shinji Itoyama; Katsuya Suzuki; Hideto Kameda; Shigehisa Mori; Masahiro Kizaki
Journal:  J Hematol Oncol       Date:  2009-06-30       Impact factor: 17.388

4.  Usefulness of tocilizumab for treating rheumatoid arthritis with myelodysplastic syndrome: A case report and literature review.

Authors:  Chuanyin Sun; Yingwan Luo; Hongyan Tong; Guanhua Xu; Jin Lin
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

5.  Risks of myeloid malignancies in patients with autoimmune conditions.

Authors:  L A Anderson; R M Pfeiffer; O Landgren; S Gadalla; S I Berndt; E A Engels
Journal:  Br J Cancer       Date:  2009-03-10       Impact factor: 7.640

Review 6.  Immune Mechanisms in Myelodysplastic Syndrome.

Authors:  Andreas Glenthøj; Andreas Due Ørskov; Jakob Werner Hansen; Sine Reker Hadrup; Casey O'Connell; Kirsten Grønbæk
Journal:  Int J Mol Sci       Date:  2016-06-15       Impact factor: 5.923
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.